GLP1R and obesity due to melanocortin 4 receptor deficiency: One exception is the class of glucagon-like peptide-1 receptor (GLP-1R) agonists, which can be used to treat not only type 2 diabetes but obesity, hyperphagia, and hypertension5–7.